Castelnuovo Berardenga, Italy

Costante Ceccarini

This inventor holds 2 USPTO granted patents. Top assignees: Chiron Corporation, Sclavo Spa. Active years: 1993-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1993-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Costante Ceccarini: Innovator in Vaccine Development

Introduction

Costante Ceccarini is a notable inventor based in Castelnuovo Berardenga, Italy. He has made significant contributions to the field of vaccine development, particularly in the area of bacterial meningitis. With a total of 2 patents to his name, Ceccarini's work has had a lasting impact on public health.

Latest Patents

Among his latest patents is a combined meningitis vaccine, which comprises Hib and MenC oligosaccharide conjugates. This innovative vaccine aims to provide comprehensive protection against bacterial meningitis. Another significant patent is for a process for the purification of Factor VIII from human plasma. This method utilizes ion exchange chromatographic columns to achieve a high level of purity for Factor VIII, which is crucial for treating hemophilia.

Career Highlights

Throughout his career, Costante Ceccarini has worked with prominent companies in the pharmaceutical industry, including Sclavo Spa and Chiron S.p.a. His experience in these organizations has allowed him to develop and refine his expertise in vaccine research and development.

Collaborations

Ceccarini has collaborated with esteemed colleagues such as Silvana Arrighi and Maria G Borri. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Costante Ceccarini's contributions to vaccine development and his innovative patents highlight his importance in the field of medical research. His work continues to influence the fight against bacterial meningitis and improve public health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…